Ozempic-maker Novo Nordisk partners with OpenAI to speed up drug development
Novo Nordisk says pilot programs would begin across research and development, manufacturing, and commercial operations, with full integration planned by the end of 2026
Original Source
Read the full article at Rappler →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.